Literature DB >> 25806187

Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection.

Christina Brzezniak1, Giuseppe Giaccone1.   

Abstract

Year:  2012        PMID： 25806187      PMCID： PMC4367544          DOI： 10.3978/j.issn.2218-6751.2012.10.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  20 in total

1.  Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.

Authors:  Robert A Ramirez; Christopher G Wang; Laura E Miller; Courtney A Adair; Allen Berry; Xinhua Yu; Thomas F O'Brien; Raymond U Osarogiagbon
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

2.  Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.

Authors:  M Riquet; D Manac'h; F Le Pimpec-Barthes; A Dujon; A Chehab
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

3.  Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma.

Authors:  E van Velzen; R J Snijder; A Brutel de la Rivière; H R Elbers; J M van den Bosch
Journal:  Ann Thorac Surg       Date:  1997-05       Impact factor: 4.330

4.  Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area.

Authors:  Jeffrey W Allen; Aamer Farooq; Thomas F O'Brien; Raymond U Osarogiagbon
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

5.  The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.

Authors:  Sirisha Jonnalagadda; Cardinale Smith; Grace Mhango; Juan P Wisnivesky
Journal:  Chest       Date:  2011-02-03       Impact factor: 9.410

6.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

7.  Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Joe B Putnam
Journal:  Chest       Date:  2010-09-09       Impact factor: 9.410

8.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

9.  Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.

Authors:  Tatsuo Nakagawa; Norihito Okumura; Yujiro Kokado; Kentaroh Miyoshi; Tomoaki Matsuoka; Kotaro Kameyama
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-05-30

10.  Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.

Authors:  Adalet Demir; Akif Turna; Celalettin Kocaturk; Mehmet Zeki Gunluoglu; Umit Aydogmus; Nur Urer; Mehmet Ali Bedirhan; Atilla Gurses; Seyit Ibrahim Dincer
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330
View more
  4 in total

1.  Response to editorial titled 'Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection'.

Authors:  Raymond U Osarogiagbon; Laura E Miller; Christopher G Wang; Robert A Ramirez
Journal:  Transl Lung Cancer Res       Date:  2013-04

Review 2.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.

Authors:  Matthew P Smeltzer; Nicholas Faris; Xinhua Yu; Robert A Ramirez; Laura E M Ramirez; Christopher G Wang; Courtney Adair; Allen Berry; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2016-06-03       Impact factor: 4.330

4.  Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.

Authors:  Yungang Sun; Qiang Zhang; Zhao Wang; Feng Shao
Journal:  Thorac Cancer       Date:  2021-04-01       Impact factor: 3.500
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.